PON1 and atherosclerosis: Mechanistically, the aortae of TIC-treated animals expressed more paraoxonase-1 (PON1), an anti-atherosclerotic molecule, in the atherosclerotic intima and exhibited higher PON1 activities in the sera, suggesting a potential role of PON1 in the superior protection by TIC against atherosclerosis.